| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 12139 |
| 1 | OMALIZUMAB | 11200 |
| 2 | ALBUTEROL SULFATE | 9433 |
| 3 | TOCILIZUMAB | 7009 |
| 4 | METHYLPHENIDATE | 6897 |
| 5 | RITUXIMAB | 5781 |
| 6 | MOMETASONE FUROATE | 4853 |
| 7 | MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE | 3122 |
| 8 | VEDOLIZUMAB | 2725 |
| 9 | ALTEPLASE | 2541 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DILUENT | 666 | 0.6447 |
| 1 | TETROFOSMIN | 409 | 0.5843 |
| 2 | PEGFILGRASTIM-CBQV | 715 | 0.4986 |
| 3 | BALOXAVIR MARBOXIL | 547 | 0.2359 |
| 4 | ETEPLIRSEN | 550 | 0.2278 |
| 5 | FARICIMAB | 1970 | 0.2221 |
| 6 | BACILLUS CALMETTE-GUERIN | 378 | 0.2122 |
| 7 | ETONOGESTREL | 12139 | 0.2109 |
| 8 | TENECTEPLASE | 316 | 0.1975 |
| 9 | MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE | 3122 | 0.1924 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 14702 |
| 1 | Anti-IgE [EPC] | 11200 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 7825 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 7096 |
| 4 | Central Nervous System Stimulant [EPC] | 7084 |
| 5 | Corticosteroid [EPC] | 6021 |
| 6 | Estrogen [EPC] | 4223 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3907 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3317 |
| 9 | Human Immunoglobulin G [EPC] | 3199 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1064 | 0.5742 |
| 1 | Interleukin-5 Antagonist [EPC] | 159 | 0.2311 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 378 | 0.2122 |
| 3 | Radioactive Diagnostic Agent [EPC] | 545 | 0.1737 |
| 4 | Cholecystokinin Analog [EPC] | 24 | 0.1569 |
| 5 | Human Immunoglobulin G [EPC] | 3199 | 0.1519 |
| 6 | Anti-IgE [EPC] | 11200 | 0.1286 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 356 | 0.0850 |
| 8 | Macrolide Antibacterial [EPC] | 86 | 0.0850 |
| 9 | Central Nervous System Stimulant [EPC] | 7084 | 0.0811 |